Andromeda | Expression screening + Thermal stability

NanoTemper brings Spectral Shift technology to the protein production market with Andromeda X, enabling biopharma and CROs

NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein...

Read

Get more information about your protein expression conditions in less time with Andromeda

Read

Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name

Last Name

Company Name

Country

State

Agree to Subscribe & Privacy Policy*

*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.

Thank you!

Error - something went wrong!

12:06

How to find expression and purification conditions that result in high levels of thermally stable membrane proteins

What you’ll learn It’s very common to experience low expression levels when producing membrane proteins — plus they’re finicky and unstable when they're outside of their native environment. Just know

Watch

Fast expression screening that reveals expression levels of properly folded recombinant proteins

Read

NanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins

SOUTH SAN FRANCISCO, Calif. June 24, 2021 — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with...

Read

Loading more...